financetom
Business
financetom
/
Business
/
Bristol Myers to invest $40 billion in the US over 5 years, CEO says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bristol Myers to invest $40 billion in the US over 5 years, CEO says
May 26, 2025 1:36 AM

May 5 (Reuters) - Bristol Myers Squibb ( BMY ) will

spend $40 billion in the US over the next five years, CEO

Christopher Boerner wrote in an opinion piece published by Stat

News on Monday.

The money will be spread across research and development,

technology and domestic manufacturing, Boerner said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Vistra Shares Today?
What's Going On With Vistra Shares Today?
Sep 19, 2024
Shares of Vistra Corp. ( VST ) are volatile on Thursday after the company announced that it had reached definitive agreements with affiliates of Nuveen Asset Management and Avenue Capital Management II. What To Know: The deal involves Vistra ( VST ) acquiring their combined 15% equity interest in Vistra Vision, a key move to consolidate its position in the...
What's Going On With Upstart Holdings Stock?
What's Going On With Upstart Holdings Stock?
Sep 19, 2024
Upstart Holdings, Inc. ( UPST ) shares are trading higher Thursday after the Federal Reserve cut interest rates by 50 basis points (bps) on Wednesday. The Details: Upstart shares are climbing amid a broad market rally as investors digest the Fed's larger-than-anticipated interest rate cut which marked the first in more than four years. The rate cut brings the federal...
Achilles Therapeutics Shares Are Trading Higher: What You Need To Know
Achilles Therapeutics Shares Are Trading Higher: What You Need To Know
Sep 19, 2024
Shares of Achilles Therapeutics plc ( ACHL ) surged Thursday after the biotechnology firm revealed plans to discontinue its TIL-based cNeT program and close its ongoing Phase I/IIa clinical trials, CHIRON and THETIS. What To Know: Achilles announced it will refocus its strategy to explore collaborations with third parties developing alternative modalities for targeting clonal neoantigens in cancer treatment. These...
What's Going On With Coinbase Stock?
What's Going On With Coinbase Stock?
Sep 19, 2024
Coinbase Global, Inc. ( COIN ) shares are trading higher Thursday as investors digest the first interest rate cut from the Federal Reserve in four years. The Details: The Federal Reserve announced a 50 basis point (bps) cut Wednesday, bringing the federal funds rate down to a range of 4.75% to 5% and increasing the appeal of risk assets like...
Copyright 2023-2026 - www.financetom.com All Rights Reserved